Argenica Therapeutics Ltd (AGN) — Financial Flexibility Index
Argenica Therapeutics Ltd (AGN) has a Financial Flexibility Index of -3.14x as of December 2025. Free cash flow of AU$-5.51 Million (operating CF AU$-5.51 Million minus capex AU$0.00) represents -3% of total liabilities (AU$1.76 Million). Check AGN goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Argenica Therapeutics Ltd Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Argenica Therapeutics Ltd across 6 annual periods. For the full cash flow conversion analysis, see Argenica Therapeutics Ltd cash flow conversion.
Annual Financial Flexibility Index for Argenica Therapeutics Ltd (2019–2024)
Year-by-year free cash flow to debt coverage for Argenica Therapeutics Ltd. Explore AGN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.50x | AU$-5.70 Million | AU$-5.70 Million | AU$3.80 Million | — |
| 2023 | 0.00x | AU$0.00 | AU$-5.06 Million | AU$2.43 Million | ▲ +100.0% |
| 2022 | -1.76x | AU$-3.30 Million | AU$-3.30 Million | AU$1.87 Million | ▲ +61.5% |
| 2021 | -4.57x | AU$-3.36 Million | AU$-3.36 Million | AU$735.91K | ▼ -85.8% |
| 2020 | -2.46x | AU$-1.05 Million | AU$-1.05 Million | AU$425.72K | ▼ -1401.4% |
| 2019 | -0.16x | AU$-58.82K | AU$-58.82K | AU$359.26K | — |